Dermestril Does NOT Cause Colon Cancer Metastasis
Dermestril (estradiol transdermal patch) does not cause colon cancer or metastases to the colon—in fact, estrogen-containing hormone therapy is associated with a LOWER risk of developing colorectal cancer.
Critical Clarification
Based on the FDA drug label, Dermestril is a topical analgesic spray for temporary relief of minor muscle pain and back aches 1. This is completely unrelated to systemic estradiol hormone therapy. However, the question appears to confuse this product with estradiol patches (also marketed as "Dermestril" in some countries), so I will address both:
If Asking About the Topical Analgesic Spray
- No cancer risk whatsoever—this is a topical pain relief product for external use only 1
- Contains no estrogen or hormonal components
- Used for muscle strain/sprain relief 1
If Asking About Estradiol Hormone Therapy (Transdermal Patches)
The Evidence on Estrogen and Colon Cancer
Estrogen-containing hormone therapy REDUCES colon cancer risk, not increases it:
- Multiple studies including the Women's Health Initiative demonstrate a LOWER risk of colon cancer in women treated with estrogen plus progestin combination therapy 2, 3 (Grade B; BEL 2)
- The American Cancer Society guidelines confirm that postmenopausal hormone therapy may decrease colorectal cancer risk 4
- This protective effect is specifically seen with combined estrogen-progestin regimens 2
Addressing "Calcified Metastases"
The research evidence shows that:
- Calcified metastases TO the colon from colorectal cancer are exceedingly rare 5, 6, 7
- When calcification occurs, it's typically IN liver metastases FROM colon cancer (11% at presentation) 6
- Calcification in metastases carries no specific prognostic significance 6
- There is absolutely no evidence linking estradiol therapy to calcified metastases
Clinical Bottom Line
Estradiol hormone therapy:
- Does NOT cause colon cancer
- Does NOT cause metastases to the colon
- Actually provides modest PROTECTION against developing colorectal cancer 2, 4, 3
- Has no association with calcified lesions in any cancer type
The topical Dermestril analgesic spray has zero cancer risk of any kind.
Important Caveats
While estrogen therapy reduces colon cancer risk, it should NOT be prescribed solely for cancer prevention due to other risks including:
- Increased breast cancer risk (especially with estrogen-progestin combinations) 2
- Thromboembolic disease 2
- Stroke (age-dependent) 2
- Potential increase in ovarian cancer with >10 years use 2
Hormone therapy remains FDA-approved only for menopausal symptoms and osteoporosis prevention, not for cancer prevention 2.